OncoLens
PrivateLast Round
Series B
Oct 24, 2024
Est. Valuation
$55M
Total Funding Raised
$27.1M
Company Overview
OncoLens is a healthtech company that provides an AI-driven, oncology-focused digital health platform that enhances cancer care through analytics, multidisciplinary collaboration tools, and clinical trial matching.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Workflow Automation, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoLens Comparables
Compare OncoLens with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Galen Health | 79% | |
| Health Catalyst | 77% | |
| Triomics | 77% | |
OncoLens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 24, 2024 | ||||
| Corporate Funding | Jul 13, 2023 | ||||
| Series A | Jan 14, 2021 | ||||
| Seed | Jan 7, 2020 | ||||
| Seed | Mar 26, 2019 |
Key People
Founding team and executive leadership
OncoLens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BIP Capital | Series A, Seed, Series B |
| SeedtoB Capital | Series A, Series B |
| Cross Border Impact Ventures | Corporate Funding, Series B |
| Atlanta Technology Angels | Seed |
| Martin Ventures | Series A, Series B |
| Panoramic Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2025
Dr. Walter "Wally" Curran joins the Advisory Board.
- May 19, 2025
Dr. Joseph Kim joins the Advisory Board.
OncoLens Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OncoLens's valuation, stock price, and market status.